Results 121 to 130 of about 31,891 (279)

Hyaline vascular variant of low-grade endometrial stromal sarcoma masquerading as ovarian tumor

open access: yesArchives of Medicine and Health Sciences, 2016
Endometrial stromal sarcomas (ESSs) are uncommon tumors of the uterus, and the cytologic features have only been reported in a number of case reports that mostly discuss the features of higher grade undifferentiated sarcomas.
Kavita Mardi, Deepak Vedant
doaj   +1 more source

Harnessing the Therapeutic Potential of Cell Secretomes and Extracellular Vesicles for Craniofacial Regenerative Applications

open access: yesJournal of Periodontal Research, EarlyView.
The scoping review summarizes the current preclinical and clinical evidence for the use of “cell‐free” therapies in craniofacial (periodontal, bone and soft‐tissue) regeneration. It also aims to highlight key challenges and strategies towards the clinical translation of these therapies.
Siddharth Shanbhag   +6 more
wiley   +1 more source

A case of ovarian endometrial stromal sarcoma: Radiological and histopathological findings

open access: yesRadiology Case Reports, 2023
Endometrial stromal sarcoma (ESS) is an uncommon uterine mesenchymal neoplasm. The primary extra-uterine location of ESS is a very rare occurrence.We present a case of a 39-year-old woman presented with severe abdominal pain, MRI showed bilateral ovarian
Meryem Sqalli Houssaini, MD   +10 more
doaj  

Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors [PDF]

open access: green, 2001
Jason I. Koontz   +8 more
openalex   +1 more source

Uterine Mesenchymal Neoplasm With a Novel CDC42::PLAG1 Fusion

open access: yesPathology International, EarlyView.
PLAG1 rearranged uterine mesenchymal neoplasms.
Pranav Dorwal   +4 more
wiley   +1 more source

Flow Cytometric DNA Analysis Using Cytokeratin Labeling for Identification of Tumor Cells in Carcinomas of the Breast and the Female Genital Tract

open access: yesAnalytical Cellular Pathology, 2001
Flow cytometric assessment of DNA‐ploidy and S‐phase fraction in malignant tumors is compromised by the heterogeneity of cell subpopulations derived from the malignant and surrounding connective tissue, e.g., tumor, stromal and inflammatory cells.
Rainer Kimmig   +3 more
doaj   +1 more source

Uterine sarcoma part III—Targeted therapy: The Taiwan Association of Gynecology (TAG) systematic review

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2016
Uterine sarcoma is a very aggressive and highly lethal disease. Even after a comprehensive staging surgery or en block cytoreduction surgery followed by multimodality therapy (often chemotherapy and/or radiation therapy), many patients relapse or present
Ming-Shyen Yen   +94 more
doaj   +1 more source

Home - About - Disclaimer - Privacy